Workflow
Virax Biolabs (VRAX) - 2025 Q2 - Quarterly Report
Virax Biolabs Virax Biolabs (US:VRAX)2024-11-21 05:03

Exhibit 99.1 Unaudited Condensed Consolidated Interim Financial Statements as of September 30, 2024 Page Condensed Consolidated Statements of Financial Position as of September 30, 2024 and March 31, 2024 (Unaudited) F-3 Condensed Consolidated Statements of Profit and Loss and Other Comprehensive Loss for the Six Months Ended September 30, 2024 and 2023 (Unaudited) F-4 Condensed Consolidated Statements of Changes in Equity for the Six Months Ended September 30, 2024 and 2023 (Unaudited) F-5 Condensed Consol ...